Why the study?
Mobile health (mHealth) interventions have potential to improve post-MI recovery and support guideline-directed medical therapy, but have limited evaluation in clinical studies and access barriers for underserved patients.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
May support mHealth for sustained post-MI adherence in underserved patients; hypothesis-generating, needs RCTs before practice change.
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide with an estimated 17.5 million deaths annually, according to the World Health Organization (WHO). CVD prevention efforts have the potential to prevent the majority of these deaths by supporting guideline-directed medical therapy (GDMT) and lifestyle modification. Mobile health (mHealth) has the potential to address this gap, but has limited evaluation in clinical studies to date. We present the case of a middle-aged patient of low socioeconomic status, with multiple comorbidities, and no prior smartphone experience, who suffered an acute myocardial infarction (MI) and was given the Corrie intervention while hospitalised. The patient demonstrated improvement in lifestyle modification, adherence to GDMT and post-MI recovery through 2.4 years follow-up. This case supports (1) the potential of mHealth interventions to enhance patient experience and outcomes, (2) intuitive design for adoption and improvement in end user experience and (3) the capability of mHealth to reach and empower underserved patients.
No takes yet. Share an insight, caveat, or question.
Hung et al. (2020) conducted a case report in Acute myocardial infarction (n=1). Corrie mobile health application platform (smartphone app, smartwatch, wireless blood pressure monitor) was evaluated on Adherence to guideline-directed medical therapy, lifestyle modification, and hospital readmissions. The Corrie mobile health platform facilitated sustained medication adherence, healthy lifestyle modifications, and avoidance of hospital readmission over 2.4 years in an underserved heart attack survivor.
Synapse has enriched 10 related papers. Consider them for comparative context: